US5942410A - Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol - Google Patents

Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol Download PDF

Info

Publication number
US5942410A
US5942410A US08/888,434 US88843497A US5942410A US 5942410 A US5942410 A US 5942410A US 88843497 A US88843497 A US 88843497A US 5942410 A US5942410 A US 5942410A
Authority
US
United States
Prior art keywords
composition
staining
metabisulfite
present
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/888,434
Inventor
Paul Pong-Shing Lam
Peter William Payne
David Michael Garner
Branko Palcic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
British Columbia Cancer Agency BCCA
Original Assignee
Oncometrics Imaging Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncometrics Imaging Corp filed Critical Oncometrics Imaging Corp
Priority to US08/888,434 priority Critical patent/US5942410A/en
Priority to US08/907,532 priority patent/US6026174A/en
Priority to CA002295545A priority patent/CA2295545C/en
Priority to EP98931863A priority patent/EP0996852A1/en
Priority to AU82029/98A priority patent/AU8202998A/en
Priority to JP2000502393A priority patent/JP4212232B2/en
Priority to PCT/CA1998/000658 priority patent/WO1999002960A1/en
Assigned to ONCOMETRICS IMAGING CORP. reassignment ONCOMETRICS IMAGING CORP. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GARNER, DAVID MICHAEL, LAM, PAUL PONG-SHING, PALCIC, BRANKO, PAYNE, PETER WILLIAM
Application granted granted Critical
Publication of US5942410A publication Critical patent/US5942410A/en
Assigned to MONOGEN, INC. reassignment MONOGEN, INC. LICENSE AND SECURITY AGREEMENT Assignors: ONCOMETRICS IMAGING CORP.
Assigned to MUSIKANTOW-GOMBRICH, SUZANNE reassignment MUSIKANTOW-GOMBRICH, SUZANNE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MOLECULAR DIAGNOSTICS, INC.
Assigned to MOLECULAR DIAGNOSTICS, INC. reassignment MOLECULAR DIAGNOSTICS, INC. SECURITY INTEREST TERMINATION Assignors: MUSIKANTOW-GOMBRICH, MS. SUZANNE
Assigned to BRITISH COLUMBIA CANCER AGENCY BRANCH reassignment BRITISH COLUMBIA CANCER AGENCY BRANCH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACCUMED INTERNATIONAL, INC., CYTOCORE INC., ONCOMETRICS IMAGING CORP.
Assigned to PERCEPTRONIX MEDICAL INC. reassignment PERCEPTRONIX MEDICAL INC. EXCLUSIVE LICENSE Assignors: THE BRITISH COLUMBIA CANCER AGENCY BRANCH
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B21/00Thiazine dyes
    • G01N15/1433
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Definitions

  • the present invention generally relates to a composition and method for staining cellular DNA, and more particularly, to a composition that includes a cationic stain and methods for its use.
  • Image cytometry has been increasingly used in cytopathology and histopathology to detect aneuploid cell populations within preneoplastic or neoplastic lesions.
  • DNA image cytometry has gained wide acceptance in pathology and cytopathology as a means to obtain diagnostic and prognostic information for human cancer. Such diagnoses require the accurate determination of cellular DNA content. Accordingly, various methods for quantitatively staining nuclear DNA have been developed. The reproducibility and reliability of several quantitative DNA stains has been recently reported. "A Comparative Study of Quantitative Stains for DNA in Image Cytometry," Mickel, U. V. and Becker, Jr., R. L., Analytical and Quantitative Cytology and Histology 1991, 13:253-260.
  • Feulgen staining techniques Feulgen, R. and Voit K., Z. Physiol. Chem. 1924, 136:57-61. Feulgen discovered that hydrolysis of fixed tissues (i.e., DNA hydrolysis) exposed the deoxypentose present in cell nuclei in an aldehyde form. Subsequently, Feulgen found that the mild acid hydrolysis of cellular DNA followed by the addition of a Schiff reagent provided a reddish-purple color to DNA-containing structures.
  • the Feulgen technique continues to be practiced as a method for quantitating cellular DNA and generally involves the steps of oxidizing nucleic acids to provide aldehydes, and reacting these aldehydes with a Schiff reagent to form a purple-red color indicative of the presence of DNA. Because the reaction is stoichiometric, the intensity of the color is directly related to the amount of DNA in the sample, provided that excess reagents are washed out.
  • a thionin-sulfite reagent was found to exclusively stain nuclei of hydrolyzed sections of mouse kidney and liver cell nuclei. Van Duijn, P., J. Histochem. Cytochem. 1956, 4:55-63.
  • the aldehyde reagent contained thionin and sulfur dioxide in a medium of t-butanol and water.
  • This thionin reagent was prepared by acidifying a solution of thionin in aqueous t-butanol (water:t-butanol, 1:1) with aqueous hydrochloric acid followed by the addition of sodium metabisulfite.
  • Van Duijn concluded from the histochemical data that the thionin-sulfite/t-butanol reagent contains one or more components that react with aldehydes, although the exact chemical nature of the reaction between thionin and sulfur dioxide and the nucleic acids was unclear.
  • the use of Feulgen staining methods has continued to present, and various compounds have been used as Feulgen stains.
  • Thionin generally regarded as a nuclear stain, is one of the more commonly used stains in the Feulgen procedure.
  • the composition of the reagent has remained unchanged (i.e., a solution of thionin and sodium metabisulfite in aqueous t-butanol adjusted to about pH 1.5 with aqueous hydrochloric acid).
  • t-butanol is an irritating substance and presents a work hazard.
  • t-butanol In contrast to other simple alcohols, t-butanol is extremely expensive (e.g., $45 per liter compared to methanol or ethanol at about $2 per liter). Perhaps most importantly, the useful shelf life of thionin/t-butanol staining solutions is about two days. Such a short shelf life precludes the storage and therefore commercial utility of such a reagent, and requires one who wishes to use the thionin reagent in a Feulgen staining method to prepare the reagent immediately prior to use.
  • a thionin-based reagent that offers the advantages of cellular DNA quantitation afforded by the traditional thionin/t-butanol staining reagent without the accompanying disadvantages associated with t-butanol, a key component of the reagent. More specifically, there exists a need for a thionin staining reagent that has a long and stable shelf life. The present invention seeks to fulfill these needs and provides further related advantages.
  • the present invention provides a composition that is useful for staining cellular DNA.
  • the composition is an aqueous alcoholic solution that includes a cationic stain having a formula: ##STR1## where R 1 and R 2 are independently selected from hydrogen and methyl, and X is a counterion; a metabisulfite; and an alcohol selected from either methanol ethanol, and mixtures of methanol and ethanol.
  • the cationic stain is thionin acetate (i.e., R 1 and R 2 are hydrogen and X is acetate).
  • a method for staining cellular DNA is provided.
  • the composition noted above is applied to a cell to provide a cell having a stained nucleus.
  • the present invention also provides a method for quantitating cellular DNA that includes the steps of staining the cell with the composition noted above to provide a cell having a stained nucleus, and then measuring the optical density of the stain nucleus to determine the presence or amount of DNA present in the nucleus.
  • the present invention provides a kit for staining cellular DNA that includes the composition noted above.
  • the present invention generally relates to a composition and method for staining cellular DNA. More specifically, the present invention provides a composition that is useful as a reagent in a Feulgen staining method and useful in both staining and determining the presence or amount of cellular DNA.
  • the composition of the present invention is an aqueous alcoholic solution that includes a cationic dye, a metabisulfite, and an alcohol preferably selected from methanol, ethanol, and mixtures of ethanol and methanol.
  • the cationic stain useful in the composition of the present invention is a phenothiazine derivative, and more specifically, a 3,7-diamino-5-phenothiazine derivative.
  • the cationic stain is represented by the following formula: ##STR2## where R 1 and R 2 are either hydrogen, methyl, or combinations of hydrogen and methyl, and X is a counterion. While the cationic stain useful in the composition of the present invention is represented by the formula above, it will be appreciated that the cationic stain may also be represented by other equivalent formulas including: ##STR3##
  • Suitable cationic stains include Azure A (R 1 and R 2 are methyl) and Azure C (R 1 is methyl and R 2 is hydrogen).
  • the cationic stain is thionin (R 1 and R 2 are hydrogen).
  • Suitable counterions X include anions that do not adversely affect the performance of the cationic stain in the staining procedure and include acetate, chloride, and bromide.
  • the counterion is acetate.
  • the cationic stain is thionin acetate (R 1 and R 2 are hydrogen and X is acetate).
  • the cationic stain is present in the composition at a concentration from about 1.0 ⁇ 10 -3 M to about 2.5 ⁇ 10 -2 M, and preferably from about 4.0 ⁇ 10 -3 M to about 8.0 ⁇ 10 -3 M.
  • the composition of the present invention also preferably includes a metabisulfite. While embodiments of the present invention that include bisulfite are useful as staining solutions, it has been found that metabisulfite containing solutions provide the best staining results. Suitable metabisulfites do not adversely affect the staining performance of the composition of the present invention. Suitable metabisulfites include metal metabisulfites such as lithium, sodium, and potassium metabisulfites. Preferably, the composition includes either sodium or potassium metabisulfite.
  • the metabisulfite is present in the composition at a concentration from about 1.0 ⁇ 10 -3 M to about 2.5 ⁇ 10 -2 M, and preferably from about 4.0 ⁇ 10 -3 M to about 8.0 ⁇ 10 -3 M.
  • a molar metabisulfite:thionin ratio of 1:1 is preferred.
  • the composition of the present invention includes a cationic stain and a metabisulfite in aqueous alcohol.
  • the aqueous alcohol solution serves to solubilize the stain and metabisulfite as well as any active DNA staining components formed in the solution. Therefore, the alcohol is preferably miscible with water and, for ease of reagent preparation, a liquid at room temperature.
  • Alcohols useful in the composition include C1 to C3 alcohols (i.e., methanol, ethanol, n-propanol and isopropanol), and mixtures of these alcohols.
  • Preferred alcohols include methanol, ethanol, and mixtures of methanol and ethanol.
  • the aqueous alcohol solution contains from about 20 to about 60 percent alcohol, and more preferably, about 40 percent alcohol.
  • the composition of the present invention is preferably an aqueous acidic solution having a pH of from about 1.0 to about 2.0, and more preferably, from about 1.3 to about 1.5. While the pH of the composition can be adjusted with any one of a number of acids, the pH of the solution is preferably adjusted with aqueous hydrochloric acid.
  • Example 1 The preparation of a representative composition of the present invention, a thionin/methanol staining solution, is described in Example 1.
  • the reaction of the above-noted cationic stain with metabisulfite results in the formation of an active ingredient that binds to hydrolyzed DNA.
  • the composition of the present invention is useful for staining cellular DNA.
  • the present invention provides a method for staining cellular DNA.
  • the composition described above is applied to cells to provide cells having stained nuclei.
  • Basic procedures such as cell fixation, dehydration, clearing, staining, and mounting, as well as specific staining methods, including Feulgen techniques, nucleic acid staining, and the staining of cellular elements, are well known to those of skill in the art.
  • the method of the present invention includes applying the composition described above to cells.
  • the composition and method of the present invention are useful in staining virtually any cell having a nucleus including, for example, epithelial, muscle, nerve, and connective tissue cells.
  • Any one of a number of cell preparations may be used in the method, for example, preparations of cells of interest include conventional smears, histological preparations, and monolayer preparations.
  • cells are deposited on a microscope slide for staining. After deposit on the slide, the cells are fixed by immersing the slide in a fixative solution and then rinsed. Alternatively, fixed cells may also be deposited on the slide for staining.
  • the cellular DNA is then hydrolyzed by immersing the slides in an acidic solution. Following another rinse, the cells are stained by immersing the slides in a staining solution. After additional rinses, the cells are then dehydrated by immersion in ethanol solutions, followed by clearing in xylene.
  • the staining results may be visualized by any one of a number of techniques including manual and automated techniques including, for example, microscopic and image cytometric techniques.
  • a detailed method for a representative staining procedure that includes the method of the present invention is described in Example 1. Although the staining procedure may be a manual procedure, the method of the present invention may also be incorporated into an automated staining procedure.
  • the staining method of the present invention is a quantitative method for staining cellular DNA
  • the combination of the steps of staining cells with the staining solution of the present invention and measuring the optical density of the resulting stained nuclei permits the determination of the presence or amount of DNA present in a cell's nucleus.
  • the present invention provides a method for quantitating cellular DNA that includes the steps of staining the cell with the composition described above, and then measuring the optical density of the stained nuclei to determine either the presence or the amount of DNA present in the nucleus.
  • the optical densities of stained nuclei may be measured by manual and automated techniques including, for example, optical scanners, microscopes, and other image cytometers.
  • Suitable instruments for measuring the optical densities of stained cells are known in the art and include those described in "The Design and Development of an Optical Scanner for Cell Biology,” Jaggi, B. and Palcic, B., IEEE Proc. Eng. Med. Biol. 1985; 2:980-985; "Cell Recognition Algorithms for the Cell Analyzer,” Jaggi, B. and Palcic B., IEEE Proc. Eng. Med. Biol. 1987; 4:1454-1456; and "Design of a Solid State Microscope," Jaggi, B., Deen, M. J., and Palcic B., Opt. Engineer 1989; 28(6):7675-682, each expressly incorporated herein by reference.
  • the methods of the present invention are useful in techniques in which stained cells are digitally imaged and the resulting digital intensity images manipulated by computer to perform a variety of cell feature measurements.
  • Cellular features such as the size, shape, and DNA content of the nucleus, and other features that describe the spatial distribution of chromatin within the nucleus, can be calculated.
  • Features that describe the chromatin distribution are collectively referred to as texture features, and texture features can be selected for their ability to differentiate between the various descriptive classes of chromatin patterns and to further provide quantitative information regarding the extent of changes in chromatin patterns associated with certain diseases including, for example, malignancy.
  • the composition and methods of the present invention are useful in nuclear texture measurements, and consequently the diagnosis and prognosis of certain diseases.
  • IOD integrated optical density
  • the composition of the present invention provides cellular DNA staining comparable to the standard thionin/t-butanol staining solution, and (2) the ability of the composition of the present invention to effectively stain cellular DNA remains essentially constant over a period of about five weeks.
  • the conventional thionin/t-butanol staining solution loses about 40 percent of its staining capacity in only four days.
  • the enhanced stability of the composition of the present invention compared to the conventional staining solution offers significant practical and commercial advantages. For example, while the conventional staining solution must be freshly prepared immediately prior to staining by the practitioner or clinician, the composition of the present invention, by virtue of their stability and long shelf life, may be prepared, stored, and used repeatedly over a relatively long period of time.
  • the extent to which the associated protein is denatured, and the extent to which DNA is made available for measurement, is highly dependent on the reagents and methods employed. For instance, in formalin fixation methods, the concentration of alcohol in the fixation reagent has been found to have a critical effect on protein denaturation and, consequently, the quantitative measurement of intracellular DNA. In general, the effect of a specific solvent or reagent on a quantitative DNA method is largely unpredictable and may typically be determined empirically through experimentation.
  • the composition and method of the present invention have been found to be effective in quantitating intracellular DNA.
  • the present composition is as effective in staining intracellular DNA as the standard t-butanol-based composition.
  • the present composition provides a staining reagent that has a stable shelf life considerably greater than the standard staining composition.
  • the present invention provides a kit for staining cellular DNA.
  • the kit of the present invention includes the composition described above.
  • composition components are contained in one or more vessels in the kit.
  • the kit includes a staining reagent that incorporates all of the components of the composition of the present invention in a single solution (i.e., an aqueous alcoholic solution of a cationic dye and a metabisulfite adjusted to about pH 1.5).
  • the kit includes a staining reagent in dry (i.e., powdered) form.
  • the kit can contain solid cationic stain in one vessel and solid metabisulfite in a second vessel.
  • the liquid components of the composition are added to the dry reagents which are then combined to provide the staining solution of the invention.
  • the kit can include a combination of solid cationic stain and metabisulfite in a single vessel.
  • the kit also includes a rinse reagent (i.e., an aqueous acidic solution of metabisulfite).
  • a rinse reagent i.e., an aqueous acidic solution of metabisulfite
  • the rinse reagent may be provided as a solid or in solution.
  • the kit can optionally include unstained, cultured cells on microscope slides (control slides) to, for example, monitor quality control of the staining procedure.
  • the kit can also include an instruction booklet that provides directions for the staining procedure and, for applicable embodiments, directions for preparing the staining solution from the kit's reagents.
  • a representative procedure for staining cellular DNA with alcohol solutions of thionin is described.
  • the reagents used in the DNA staining procedure including methanol and t-butanol solutions of thionin, and fixative and rinse solutions, were prepared as described below.
  • the reagents prepared as described above were then used to stain cellular DNA by the following method.
  • Preparations of cells of interest e.g., cells from uterine cervix samples
  • cells of interest including conventional smears and monolayer preparations, may be used in the method.
  • cells are generally deposited on a microscope slide for staining.
  • This example compares the cellular DNA staining performance of thionin/methanol and thionin/t-butanol staining solutions over time.
  • thionin solutions were prepared in either methanol or t-butanol, as described in Example 1 above, and cellular preparations were stained and the optical densities of the stained nuclei measured.
  • cellular stainings with each thionin solution were performed at regular time intervals (see Table 1 below) with the same stock staining solution.
  • the comparative experiment determined the useful shelf life of each of the specific thionin staining reagents studied.

Abstract

A composition and method for staining cellular DNA are disclosed. The composition of the present invention is an aqueous alcoholic solution that includes a cationic stain, a metabisulfite, and an alcohol preferably selected from methanol, ethanol, and mixtures thereof. In a preferred embodiment, the cationic stain is thionin.

Description

FIELD OF THE INVENTION
The present invention generally relates to a composition and method for staining cellular DNA, and more particularly, to a composition that includes a cationic stain and methods for its use.
BACKGROUND OF THE INVENTION
Image cytometry has been increasingly used in cytopathology and histopathology to detect aneuploid cell populations within preneoplastic or neoplastic lesions. DNA image cytometry has gained wide acceptance in pathology and cytopathology as a means to obtain diagnostic and prognostic information for human cancer. Such diagnoses require the accurate determination of cellular DNA content. Accordingly, various methods for quantitatively staining nuclear DNA have been developed. The reproducibility and reliability of several quantitative DNA stains has been recently reported. "A Comparative Study of Quantitative Stains for DNA in Image Cytometry," Mickel, U. V. and Becker, Jr., R. L., Analytical and Quantitative Cytology and Histology 1991, 13:253-260.
Included among the various techniques for staining cellular DNA are Feulgen staining techniques. Feulgen, R. and Voit K., Z. Physiol. Chem. 1924, 136:57-61. Feulgen discovered that hydrolysis of fixed tissues (i.e., DNA hydrolysis) exposed the deoxypentose present in cell nuclei in an aldehyde form. Subsequently, Feulgen found that the mild acid hydrolysis of cellular DNA followed by the addition of a Schiff reagent provided a reddish-purple color to DNA-containing structures. The Feulgen technique continues to be practiced as a method for quantitating cellular DNA and generally involves the steps of oxidizing nucleic acids to provide aldehydes, and reacting these aldehydes with a Schiff reagent to form a purple-red color indicative of the presence of DNA. Because the reaction is stoichiometric, the intensity of the color is directly related to the amount of DNA in the sample, provided that excess reagents are washed out.
In 1954, a thionin-sulfite reagent was found to exclusively stain nuclei of hydrolyzed sections of mouse kidney and liver cell nuclei. Van Duijn, P., J. Histochem. Cytochem. 1956, 4:55-63. The aldehyde reagent contained thionin and sulfur dioxide in a medium of t-butanol and water. This thionin reagent was prepared by acidifying a solution of thionin in aqueous t-butanol (water:t-butanol, 1:1) with aqueous hydrochloric acid followed by the addition of sodium metabisulfite. Van Duijn concluded from the histochemical data that the thionin-sulfite/t-butanol reagent contains one or more components that react with aldehydes, although the exact chemical nature of the reaction between thionin and sulfur dioxide and the nucleic acids was unclear. The use of Feulgen staining methods has continued to present, and various compounds have been used as Feulgen stains. Thionin, generally regarded as a nuclear stain, is one of the more commonly used stains in the Feulgen procedure.
Despite the many years that have passed since the original report of the thionin-Feulgen stain reagent, the composition of the reagent has remained unchanged (i.e., a solution of thionin and sodium metabisulfite in aqueous t-butanol adjusted to about pH 1.5 with aqueous hydrochloric acid).
Although the Feulgen thionin staining method developed in the 1950s does facilitate quantitative DNA measurements, the use of t-butanol as a solvent for the traditional thionin staining reagent is not without its drawbacks. First, t-butanol is an irritating substance and presents a work hazard. Second, because t-butanol has a melting point of about 25° C., it is often a solid at room temperature and requires heating and melting so that it may be dispensed as a liquid in the preparation of the reagent. Unlike most other low molecular weight alcohols, t-butanol is difficult to dispose of properly. Because of its hazardous nature, there are also shipping restrictions associated with t-butanol. In contrast to other simple alcohols, t-butanol is extremely expensive (e.g., $45 per liter compared to methanol or ethanol at about $2 per liter). Perhaps most importantly, the useful shelf life of thionin/t-butanol staining solutions is about two days. Such a short shelf life precludes the storage and therefore commercial utility of such a reagent, and requires one who wishes to use the thionin reagent in a Feulgen staining method to prepare the reagent immediately prior to use.
Accordingly, there exists a need for a thionin-based reagent that offers the advantages of cellular DNA quantitation afforded by the traditional thionin/t-butanol staining reagent without the accompanying disadvantages associated with t-butanol, a key component of the reagent. More specifically, there exists a need for a thionin staining reagent that has a long and stable shelf life. The present invention seeks to fulfill these needs and provides further related advantages.
SUMMARY OF THE INVENTION
In one aspect, the present invention provides a composition that is useful for staining cellular DNA. Generally, the composition is an aqueous alcoholic solution that includes a cationic stain having a formula: ##STR1## where R1 and R2 are independently selected from hydrogen and methyl, and X is a counterion; a metabisulfite; and an alcohol selected from either methanol ethanol, and mixtures of methanol and ethanol. In a preferred embodiment, the cationic stain is thionin acetate (i.e., R1 and R2 are hydrogen and X is acetate).
In another aspect of the present invention, a method for staining cellular DNA is provided. In the method, the composition noted above is applied to a cell to provide a cell having a stained nucleus. The present invention also provides a method for quantitating cellular DNA that includes the steps of staining the cell with the composition noted above to provide a cell having a stained nucleus, and then measuring the optical density of the stain nucleus to determine the presence or amount of DNA present in the nucleus.
In still another aspect, the present invention provides a kit for staining cellular DNA that includes the composition noted above.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The present invention generally relates to a composition and method for staining cellular DNA. More specifically, the present invention provides a composition that is useful as a reagent in a Feulgen staining method and useful in both staining and determining the presence or amount of cellular DNA. The composition of the present invention is an aqueous alcoholic solution that includes a cationic dye, a metabisulfite, and an alcohol preferably selected from methanol, ethanol, and mixtures of ethanol and methanol.
The cationic stain useful in the composition of the present invention is a phenothiazine derivative, and more specifically, a 3,7-diamino-5-phenothiazine derivative. The cationic stain is represented by the following formula: ##STR2## where R1 and R2 are either hydrogen, methyl, or combinations of hydrogen and methyl, and X is a counterion. While the cationic stain useful in the composition of the present invention is represented by the formula above, it will be appreciated that the cationic stain may also be represented by other equivalent formulas including: ##STR3## Suitable cationic stains include Azure A (R1 and R2 are methyl) and Azure C (R1 is methyl and R2 is hydrogen). In a preferred embodiment, the cationic stain is thionin (R1 and R2 are hydrogen). Suitable counterions X include anions that do not adversely affect the performance of the cationic stain in the staining procedure and include acetate, chloride, and bromide. In a preferred embodiment, the counterion is acetate. In a particularly preferred embodiment, the cationic stain is thionin acetate (R1 and R2 are hydrogen and X is acetate).
The cationic stain is present in the composition at a concentration from about 1.0×10-3 M to about 2.5×10-2 M, and preferably from about 4.0×10-3 M to about 8.0×10-3 M.
In addition to the cationic stain, the composition of the present invention also preferably includes a metabisulfite. While embodiments of the present invention that include bisulfite are useful as staining solutions, it has been found that metabisulfite containing solutions provide the best staining results. Suitable metabisulfites do not adversely affect the staining performance of the composition of the present invention. Suitable metabisulfites include metal metabisulfites such as lithium, sodium, and potassium metabisulfites. Preferably, the composition includes either sodium or potassium metabisulfite. Preferably, the metabisulfite is present in the composition at a concentration from about 1.0×10-3 M to about 2.5×10-2 M, and preferably from about 4.0×10-3 M to about 8.0×10-3 M. In contrast to Feulgen staining solutions known in the art that have a molar ratio of metabisulfite:thionin of 4-10:1, in the composition of the present invention, a molar metabisulfite:thionin ratio of 1:1 is preferred.
The composition of the present invention includes a cationic stain and a metabisulfite in aqueous alcohol. The aqueous alcohol solution serves to solubilize the stain and metabisulfite as well as any active DNA staining components formed in the solution. Therefore, the alcohol is preferably miscible with water and, for ease of reagent preparation, a liquid at room temperature. Alcohols useful in the composition include C1 to C3 alcohols (i.e., methanol, ethanol, n-propanol and isopropanol), and mixtures of these alcohols. Preferred alcohols include methanol, ethanol, and mixtures of methanol and ethanol. Preferably, the aqueous alcohol solution contains from about 20 to about 60 percent alcohol, and more preferably, about 40 percent alcohol. The composition of the present invention is preferably an aqueous acidic solution having a pH of from about 1.0 to about 2.0, and more preferably, from about 1.3 to about 1.5. While the pH of the composition can be adjusted with any one of a number of acids, the pH of the solution is preferably adjusted with aqueous hydrochloric acid.
The preparation of a representative composition of the present invention, a thionin/methanol staining solution, is described in Example 1.
Generally, the reaction of the above-noted cationic stain with metabisulfite results in the formation of an active ingredient that binds to hydrolyzed DNA. Thus, the composition of the present invention is useful for staining cellular DNA. Accordingly, in another aspect, the present invention provides a method for staining cellular DNA. In the method, the composition described above is applied to cells to provide cells having stained nuclei. Basic procedures, such as cell fixation, dehydration, clearing, staining, and mounting, as well as specific staining methods, including Feulgen techniques, nucleic acid staining, and the staining of cellular elements, are well known to those of skill in the art. Basic cytological and histochemical techniques are described in Histological and Histochemical Methods: Theory and Practice, 2nd Ed., J. A. Kierenan, ed., Pergamon Press, New York, 1990, and Animal Tissue Techniques 4th Ed., Gretchen L. Humason, W.H. Freeman & Company, San Francisco, 1979, both expressly incorporated herein by reference.
As noted above, the method of the present invention includes applying the composition described above to cells. The composition and method of the present invention are useful in staining virtually any cell having a nucleus including, for example, epithelial, muscle, nerve, and connective tissue cells. Any one of a number of cell preparations may be used in the method, for example, preparations of cells of interest include conventional smears, histological preparations, and monolayer preparations. Generally, cells are deposited on a microscope slide for staining. After deposit on the slide, the cells are fixed by immersing the slide in a fixative solution and then rinsed. Alternatively, fixed cells may also be deposited on the slide for staining. After rinsing, the cellular DNA is then hydrolyzed by immersing the slides in an acidic solution. Following another rinse, the cells are stained by immersing the slides in a staining solution. After additional rinses, the cells are then dehydrated by immersion in ethanol solutions, followed by clearing in xylene. At this point, the staining results may be visualized by any one of a number of techniques including manual and automated techniques including, for example, microscopic and image cytometric techniques. A detailed method for a representative staining procedure that includes the method of the present invention is described in Example 1. Although the staining procedure may be a manual procedure, the method of the present invention may also be incorporated into an automated staining procedure.
Because the staining method of the present invention is a quantitative method for staining cellular DNA, the combination of the steps of staining cells with the staining solution of the present invention and measuring the optical density of the resulting stained nuclei permits the determination of the presence or amount of DNA present in a cell's nucleus. Thus, in another aspect, the present invention provides a method for quantitating cellular DNA that includes the steps of staining the cell with the composition described above, and then measuring the optical density of the stained nuclei to determine either the presence or the amount of DNA present in the nucleus. The optical densities of stained nuclei may be measured by manual and automated techniques including, for example, optical scanners, microscopes, and other image cytometers. Suitable instruments for measuring the optical densities of stained cells are known in the art and include those described in "The Design and Development of an Optical Scanner for Cell Biology," Jaggi, B. and Palcic, B., IEEE Proc. Eng. Med. Biol. 1985; 2:980-985; "Cell Recognition Algorithms for the Cell Analyzer," Jaggi, B. and Palcic B., IEEE Proc. Eng. Med. Biol. 1987; 4:1454-1456; and "Design of a Solid State Microscope," Jaggi, B., Deen, M. J., and Palcic B., Opt. Engineer 1989; 28(6):7675-682, each expressly incorporated herein by reference.
The methods of the present invention are useful in techniques in which stained cells are digitally imaged and the resulting digital intensity images manipulated by computer to perform a variety of cell feature measurements. Cellular features, such as the size, shape, and DNA content of the nucleus, and other features that describe the spatial distribution of chromatin within the nucleus, can be calculated. Features that describe the chromatin distribution are collectively referred to as texture features, and texture features can be selected for their ability to differentiate between the various descriptive classes of chromatin patterns and to further provide quantitative information regarding the extent of changes in chromatin patterns associated with certain diseases including, for example, malignancy. Thus, the composition and methods of the present invention are useful in nuclear texture measurements, and consequently the diagnosis and prognosis of certain diseases. Nuclear texture measurements in image cytometry and their utility in the diagnosis and prognosis of human cancer are described in A. Doudkine, C. MacAulay, N. Poulin, and B. Palcic, "Nuclear Texture Measurements in Image Cytometry," Pathologica 1995; 87:286-299, expressly incorporated herein by reference.
The integrated optical density (IOD), a nuclear feature measurement, for cells stained by representative staining solutions of the present invention and the traditional thionin/t-butanol stain are presented in Example 3.
As noted above, one of the most significant drawbacks to the traditional thionin/t-butanol Feulgen staining technique is the short shelf life of the t-butanol-based staining solution. In contrast, the methanol- and ethanol-based compositions of the present invention have considerable and significantly longer shelf life. A comparison of the staining performance of representative compositions of the present invention (i.e., thionin/methanol and thionin/ethanol staining solutions) and the traditional Feulgen staining reagent (i.e., thionin/t-butanol staining solution) is described in Example 2. The results summarized in Tables 1 and 2 clearly demonstrate that (1) the composition of the present invention provides cellular DNA staining comparable to the standard thionin/t-butanol staining solution, and (2) the ability of the composition of the present invention to effectively stain cellular DNA remains essentially constant over a period of about five weeks. In contrast, the conventional thionin/t-butanol staining solution loses about 40 percent of its staining capacity in only four days. The enhanced stability of the composition of the present invention compared to the conventional staining solution offers significant practical and commercial advantages. For example, while the conventional staining solution must be freshly prepared immediately prior to staining by the practitioner or clinician, the composition of the present invention, by virtue of their stability and long shelf life, may be prepared, stored, and used repeatedly over a relatively long period of time.
The utility and success of the composition and method of the present invention in quantitatively staining intracellular DNA is noteworthy in view of the well established sensitivity of quantitative DNA methods to various chemical treatments. Quantitative DNA measurements are known to be highly sensitive to, for example, cell fixation methods. Fixation methods, and more specifically the reagents and solvents used in a particular method, have been shown to dramatically affect intracellular DNA quantitation. The variation in the amount of cellular DNA available for staining has been suggested as one reason for the variation observed in certain methods. Within a cell, DNA is associated with protein. Cell fixation serves, in part, to denature the associated protein and to expose the DNA thus making the DNA available for staining. Fixation methods typically employ solvents, including alcohols, to effect protein denaturation. Generally, the extent to which the associated protein is denatured, and the extent to which DNA is made available for measurement, is highly dependent on the reagents and methods employed. For instance, in formalin fixation methods, the concentration of alcohol in the fixation reagent has been found to have a critical effect on protein denaturation and, consequently, the quantitative measurement of intracellular DNA. In general, the effect of a specific solvent or reagent on a quantitative DNA method is largely unpredictable and may typically be determined empirically through experimentation.
Despite the well-known sensitivity of quantitative DNA methods to various reagents and solvents, the composition and method of the present invention have been found to be effective in quantitating intracellular DNA. As demonstrated by the staining results presented in Examples 2 and 3, the present composition is as effective in staining intracellular DNA as the standard t-butanol-based composition. Furthermore, the present composition provides a staining reagent that has a stable shelf life considerably greater than the standard staining composition.
Accordingly, in another aspect, the present invention provides a kit for staining cellular DNA. The kit of the present invention includes the composition described above. Generally, composition components are contained in one or more vessels in the kit. For example, in one embodiment, the kit includes a staining reagent that incorporates all of the components of the composition of the present invention in a single solution (i.e., an aqueous alcoholic solution of a cationic dye and a metabisulfite adjusted to about pH 1.5). Alternatively, in another embodiment, the kit includes a staining reagent in dry (i.e., powdered) form. In such an embodiment, the kit can contain solid cationic stain in one vessel and solid metabisulfite in a second vessel. For this embodiment, the liquid components of the composition are added to the dry reagents which are then combined to provide the staining solution of the invention. In yet another embodiment, the kit can include a combination of solid cationic stain and metabisulfite in a single vessel.
In addition to the staining reagent, the kit also includes a rinse reagent (i.e., an aqueous acidic solution of metabisulfite). As noted above for the staining reagent, the rinse reagent may be provided as a solid or in solution. The kit can optionally include unstained, cultured cells on microscope slides (control slides) to, for example, monitor quality control of the staining procedure. The kit can also include an instruction booklet that provides directions for the staining procedure and, for applicable embodiments, directions for preparing the staining solution from the kit's reagents.
The following examples are provided for the purposes of illustration, and not limitation.
EXAMPLES Example 1 Representative Procedure for Cellular DNA Staining
In this example, a representative procedure for staining cellular DNA with alcohol solutions of thionin is described. The reagents used in the DNA staining procedure, including methanol and t-butanol solutions of thionin, and fixative and rinse solutions, were prepared as described below.
Stain Reagent Preparations:
A. Representative Staining Solution of Present Invention
Thionin/methanol Staining Solution
1. Add 0.5 g thionin (Aldrich Chemical Co., Milwaukee, Wis.) and 0.5 g sodium metabisulfite to a 500 ml glass bottle with a stirring bar.
2. Add 200 ml methanol. Mix well.
3. Add 250 ml distilled water.
4. Add 50 ml 1N hydrochloric acid and cap the bottle.
5. Stir stain solution for one hour. Protect solution from light by wrapping the bottle with aluminum foil. Do not refrigerate.
6. Filter stain solution through filter paper (No. 1 grade) in a fume hood immediately prior to use.
B. Conventional Feulgen Staining Solution
Thionin/t-butanol Staining Solution
1. Add 0.5 g thionin to 435 ml distilled water in a 2000 ml Erlenmeyer flask.
2. Heat solution to boiling for about 5 minutes and then allow to cool to about room temperature.
3. Add 435 ml t-butanol. (If necessary, melt the t-butanol in a waterbath. The melting point of t-butanol is 25-26° C. and therefore is a solid at temperatures below about 25° C.).
4. Add 130 ml 1N aqueous hydrochloric acid.
5. Add 8.7 g sodium metabisulfite.
6. Add stirring bar and seal container with Parafilm M.
7. Stir stain solution for at least 1 hour. Protect from light and do not refrigerate.
8. Filter stain solution through filter paper (No. 1 grade) in a fume hood just prior to use.
Other Reagent Preparations:
Bohm-Sprenger Fixative
1. Combine 320 ml methanol and 60 ml aqueous formaldehyde (37%) in a 500 ml glass bottle.
2. Add 20 ml glacial acetic acid.
3. Mix well and seal with Parafilm M.
Rinse Solution
1. Dissolve 7.5 g sodium metabisulfite in 1425 ml distilled water in a 2000 ml Erlenmeyer flask.
2. Add 75 ml 1N aqueous hydrochloric acid.
3. Add stirring bar and stir until dissolved. Seal flask with Parafilm M.
1% Acid Alcohol
1. Mix 280 ml of absolute ethanol and 120 ml distilled water.
2. Add 4 ml concentrated hydrochloric acid.
3. Mix well.
The reagents prepared as described above were then used to stain cellular DNA by the following method. Preparations of cells of interest (e.g., cells from uterine cervix samples), including conventional smears and monolayer preparations, may be used in the method. In the method, cells are generally deposited on a microscope slide for staining.
Staining Procedure:
1. Deposit cells on a microscope slide.
2. Fix cells by immersing slide in Bohm-Sprenger fixative: 30-60 minutes.
3. Rinse slide in distilled water: 1 minute, agitate.
4. Hydrolyze cellular DNA by immersing slide in 5N hydrochloric acid: 60 minutes at room temperature.
5. Rinse slides in distilled water: 15 dips, agitate.
6. Stain cells by applying freshly filtered thionin stain solution: 75 minutes.
7. Wash slides in distilled water: 6 changes, 20 dips each.
8. Rinse slides in freshly prepared rinse solution: 3 changes: 30 seconds for the first two rinses, 5 minutes for the last rinse.
9. Rinse slides in distilled water: 3 changes, 20 dips each.
10. For mucoidal samples only:
Optionally rinse slides in 1% acid alcohol: 2 minutes.
11. Rinse slides in distilled water: 3 changes, 20 dips each.
12. Dehydrate cells by sequentially immersing the slides in 50%, 75% aqueous ethanol and two changes of 100% ethanol: 1 minute each.
13. Clear slides by immersing in xylene: 5 minutes.
14. Mount coverslips on slides.
15. Identify slides with barcode labels if desired.
Example 2 Cellular DNA Staining Results: Performance Over Time
This example compares the cellular DNA staining performance of thionin/methanol and thionin/t-butanol staining solutions over time. In the comparative study, thionin solutions were prepared in either methanol or t-butanol, as described in Example 1 above, and cellular preparations were stained and the optical densities of the stained nuclei measured. To determine the effect of time on the performance of each thionin staining solution, cellular stainings with each thionin solution were performed at regular time intervals (see Table 1 below) with the same stock staining solution. In effect, the comparative experiment determined the useful shelf life of each of the specific thionin staining reagents studied.
Cellular preparations (HL-60 cells from American Type Culture Selection) were stained by the procedure described in Example 1 above. The integrated optical density (IOD) for each sample was determined by quantitative image cytometry using an optical scanner and by the methods described in "CytoSavant and Its Use in Automated Screening of Cervical Smears," Garner, D. M., Harrison, A., MacAulay, C., and Palcic, B., in Compendium on the Computerized Cytology and Histology Laboratory, Wied, G. L., Bartels, P. H., Rosenthal, D. L., and Schenck, U., eds., Tutorials of Cytology, Chicago, 1994; "The Design and Development of an Optical Scanner for Cell Biology," Jaggi, B. and Palcic, B., IEEE Proc. Eng. Med. Biol. 1985; 2:980-985; "Cell Recognition Algorithms for the Cell Analyzer," Jaggi, B. and Palcic B., IEEE Proc. Eng. Med. Biol. 1987; 4:1454-1456; and "Design of a Solid State Microscope," Jaggi, B., Deen, M. J., and Palcic B., Opt. Engineer 1989; 28(6):7675-682, all expressly incorporated herein by reference. For each data point, three slides were stained followed by the measurement of their optical density. The performance (i.e., the capacity to stain cellular DNA and provide optically dense nuclei) of the two thionin staining solutions is summarized in Table 1 below.
______________________________________                                    
Thionin Solution                                                          
Day    t-Butanol     Methanol  Ethanol                                    
______________________________________                                    
0      114.7 ± 4.2                                                     
                     120.0 ± 2.0                                       
                               120.9 ± 1.6                             
1      117.3 ± 3.5                                                     
                     --        --                                         
2      123.0 ± 5.7                                                     
                     --        --                                         
3       85.3 ± 3.1                                                     
                     --        --                                         
4       68.3 ± 4.7                                                     
                     --        --                                         
7      --            119.7 ± 3.1                                       
                               116.2 ± 5.6                             
14     --            119.3 ± 2.1                                       
                               118.9 ± 1.2                             
21     --            117.7 ± 2.5                                       
                               113.3 ± 3.3                             
28     --            119.7 ± 2.1                                       
                               106.5 ± 1.8                             
35     --            112.0 ± 2.0                                       
                               114.4 ± 6.0                             
______________________________________                                    
As shown in Table 1, the performance of the t-butanol-based thionin staining solution decreases dramatically and rapidly over time. After only four days, the effectiveness of this solution, as measured by the optical density of cells stained, has decreased to about 60% of its original value. In contrast, the performance of the thionin/methanol and thionin/ethanol staining solutions remains essentially unchanged over a period of four weeks. These results demonstrate that methanolic and ethanolic solutions of thionin are significantly more stable than solutions of thionin in t-butanol. The results also demonstrate the effectiveness and comparability of methanol and ethanol as solvents for thionin staining, and their superiority to t-butanol as a thionin stain solvent.
While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.

Claims (24)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A composition comprising a cationic stain having the formula: ##STR4## wherein R1 and R2 are independently selected from the group consisting of hydrogen and methyl, and X is a counterion;
a metabisulfite; and an aqueous alcoholic solution comprising an alcohol selected from the group consisting of methanol, ethanol, and mixtures thereof.
2. The composition of claim 1 wherein R1 and R2 are hydrogen.
3. The composition of claim 1 wherein R1 is methyl and R2 is hydrogen.
4. The composition of claim 1 wherein X is selected from the group consisting of acetate, chloride, and bromide.
5. The composition of claim 1 wherein X is acetate.
6. The composition of claim 1 wherein R1 and R2 are hydrogen and X is acetate.
7. The composition of claim 1 wherein the cationic stain is present in the composition at a concentration of from about 1.0×10-3 M to about 2.5×10-2 M.
8. The composition of claim 1 wherein the cationic stain is present in the composition at a concentration of from about 4.0×10-3 M to about 8.0×10-3 M.
9. The composition of claim 1 wherein the metabisulfite is selected from the group consisting of lithium, sodium, and potassium metabisulfites.
10. The composition of claim 1 wherein the metabisulfite is present in the composition at a concentration of from about 1.0×10-3 M to about 2.5×10-2 M.
11. The composition of claim 1 wherein the metabisulfite is present in the composition at a concentration of from about 4.0×10-3 M to about 8.0×10-3 M.
12. The composition of claim 1 wherein the composition has a pH of from about 1.0 to about 2.0.
13. The composition of claim 1 wherein the composition has a pH of from about 1.3 to about 1.5.
14. A method for staining cellular DNA comprising applying a staining solution to a cell to provide a cell having a stained nucleus, wherein the staining solution comprises a cationic stain having the formula: ##STR5## wherein R1 and R2 are independently selected from the group consisting of hydrogen and methyl, and X is a counterion;
a metabisulfite; and an aqueous alcoholic solution comprising an alcohol selected from the group consisting of methanol, ethanol, and mixtures thereof.
15. The method of claim 14 wherein R1 and R2 are hydrogen.
16. The method of claim 14 wherein R1 is methyl and R2 is hydrogen.
17. The method of claim 14 wherein X is selected from the group consisting of acetate, chloride, and bromide.
18. The method of claim 14 wherein R1 and R2 are hydrogen and X is acetate.
19. The method of claim 14 wherein the cationic stain is present in the composition at a concentration of from about 1.0×10-3 M to about 2.5×10-2 M.
20. The method of claim 14 wherein the metabisulfite is selected from the group consisting of lithium, sodium, and potassium metabisulfites.
21. The method of claim 14 wherein the metabisulfite is present in the composition at a concentration of from about 1.033 10-3 M to about 2.5×10-2 M.
22. The method of claim 14 wherein the composition has a pH of from about 1.0 to about 2.0.
23. A method for quantitating cellular DNA comprising:
staining the cell with a composition to provide a cell having a stained nucleus, wherein the composition comprises a cationic stain having the formula: ##STR6## wherein R1 and R2 are selected from the group consisting of hydrogen and methyl, and X is a counterion;
a metabisulfite; and an aqueous alcoholic solution comprising an alcohol selected from the group consisting of methanol, ethanol, and mixtures thereof; and
measuring the optical density of the stained nucleus as an indication of the presence or amount of DNA present in the nucleus.
24. A kit for staining cellular DNA comprising a cationic stain having the formula: ##STR7## wherein R1 and R2 are selected from the group consisting of hydrogen and methyl, and X is a counterion;
a metabisulfite; and an aqueous alcoholic solution comprising an alcohol selected from the group consisting of methanol, ethanol, and mixtures thereof;
wherein the cationic stain, metabisulfite, and alcohol are contained in one or more vessels.
US08/888,434 1992-10-14 1997-07-07 Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol Expired - Lifetime US5942410A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US08/888,434 US5942410A (en) 1997-07-07 1997-07-07 Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol
US08/907,532 US6026174A (en) 1992-10-14 1997-08-08 System and method for automatically detecting malignant cells and cells having malignancy-associated changes
EP98931863A EP0996852A1 (en) 1997-07-07 1998-07-07 Composition and method for staining cellular dna
AU82029/98A AU8202998A (en) 1997-07-07 1998-07-07 Composition and method for staining cellular dna
JP2000502393A JP4212232B2 (en) 1997-07-07 1998-07-07 Compositions and methods for staining cellular DNA
PCT/CA1998/000658 WO1999002960A1 (en) 1997-07-07 1998-07-07 Composition and method for staining cellular dna
CA002295545A CA2295545C (en) 1997-07-07 1998-07-07 Composition and method for staining cellular dna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/888,434 US5942410A (en) 1997-07-07 1997-07-07 Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/644,893 Continuation-In-Part US5889881A (en) 1992-10-14 1996-05-10 Method and apparatus for automatically detecting malignancy-associated changes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US08/907,532 Continuation-In-Part US6026174A (en) 1992-10-14 1997-08-08 System and method for automatically detecting malignant cells and cells having malignancy-associated changes

Publications (1)

Publication Number Publication Date
US5942410A true US5942410A (en) 1999-08-24

Family

ID=25393167

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/888,434 Expired - Lifetime US5942410A (en) 1992-10-14 1997-07-07 Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol

Country Status (6)

Country Link
US (1) US5942410A (en)
EP (1) EP0996852A1 (en)
JP (1) JP4212232B2 (en)
AU (1) AU8202998A (en)
CA (1) CA2295545C (en)
WO (1) WO1999002960A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348325B1 (en) 1999-10-29 2002-02-19 Cytyc Corporation Cytological stain composition
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US6593102B2 (en) 1999-10-29 2003-07-15 Cytyc Corporation Cytological stain composition
US20040042646A1 (en) * 2002-08-29 2004-03-04 Macaulay Calum E. Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer
US20040092026A1 (en) * 2002-11-13 2004-05-13 Ferguson Gary William Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20050059955A1 (en) * 1999-10-22 2005-03-17 Dave Delaney Catheter devices and methods for their use in the treatment of calcified vascular occlusions
US20050202524A1 (en) * 2004-03-15 2005-09-15 Brusilovskiy Arkadiy I. Tissue staining protocol and composition
US20060161099A1 (en) * 1998-07-15 2006-07-20 Constantz Brent R Methods and devices for reducing the mineral content of vascular calcified lesions
US20060199243A1 (en) * 2005-03-03 2006-09-07 Garner David M Cytological stain composition and methods of use
US20070173784A1 (en) * 1999-10-22 2007-07-26 Peter Johansson Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
CN111879592A (en) * 2020-08-25 2020-11-03 湖南品胜生物技术有限公司 Anti-falling cell DNA quantitative staining solution and preparation method thereof
CN111999144A (en) * 2020-08-25 2020-11-27 湖南品胜生物技术有限公司 Anti-falling cell DNA quantitative staining method

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU754722B2 (en) 1998-05-09 2002-11-21 Ikonisys Inc. Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
US7901887B2 (en) 1998-05-09 2011-03-08 Ikonisys, Inc. Automated cancer diagnostic methods using fish
WO2001037192A1 (en) 1999-11-18 2001-05-25 Ikonisys, Inc. Method and apparatus for computer controlled cell based diagnosis
TR200102815T1 (en) * 2000-01-31 2002-05-21 Zila, Inc. In vivo staining compounds and methods to be used for the detection of tissue with dysplasia.
CN102967499A (en) * 2012-12-13 2013-03-13 麦克奥迪(厦门)医疗诊断系统有限公司 Cell nucleus DNA (Deoxyribose Nucleic Acid) staining method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314293A2 (en) * 1987-09-21 1989-05-03 Cell Analysis Systems, Inc. A kit and method for analyses of biological specimens
US4998284A (en) * 1987-11-17 1991-03-05 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
US5016283A (en) * 1985-11-04 1991-05-14 Cell Analysis Systems, Inc. Methods and apparatus for immunoploidy analysis
EP0445434A2 (en) * 1990-03-07 1991-09-11 Cytyc Corporation Thionin stain technique
US5281517A (en) * 1985-11-04 1994-01-25 Cell Analysis Systems, Inc. Methods for immunoploidy analysis
US5432056A (en) * 1993-11-15 1995-07-11 Ventana Medical Systems, Inc. Bisulfite-based tissue fixative
US5485527A (en) * 1985-11-04 1996-01-16 Becton Dickinson And Company Apparatus and method for analyses of biological specimens

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5016283A (en) * 1985-11-04 1991-05-14 Cell Analysis Systems, Inc. Methods and apparatus for immunoploidy analysis
US5109429A (en) * 1985-11-04 1992-04-28 Cell Analysis Systems,Inc. Apparatus and method for analyses of biological specimens
US5281517A (en) * 1985-11-04 1994-01-25 Cell Analysis Systems, Inc. Methods for immunoploidy analysis
US5485527A (en) * 1985-11-04 1996-01-16 Becton Dickinson And Company Apparatus and method for analyses of biological specimens
EP0314293A2 (en) * 1987-09-21 1989-05-03 Cell Analysis Systems, Inc. A kit and method for analyses of biological specimens
US4998284A (en) * 1987-11-17 1991-03-05 Cell Analysis Systems, Inc. Dual color camera microscope and methodology for cell staining and analysis
EP0445434A2 (en) * 1990-03-07 1991-09-11 Cytyc Corporation Thionin stain technique
US5432056A (en) * 1993-11-15 1995-07-11 Ventana Medical Systems, Inc. Bisulfite-based tissue fixative

Non-Patent Citations (49)

* Cited by examiner, † Cited by third party
Title
Bulstra, S.K. et al., "Thionin Staining of Paraffin and Plastic Embedded Sections of Cartilage," Biotechnic & Histochemistry, vol. 68, No. 1, 1993, pp. 20-28.
Bulstra, S.K. et al., Thionin Staining of Paraffin and Plastic Embedded Sections of Cartilage, Biotechnic & Histochemistry, vol. 68, No. 1, 1993, pp. 20 28. *
Cooper, J.D., et al., "Accurate Counting of Neurons in Frozen Sections: Some Necessary Precautions," J. Anatomy,vol. 157, 1988, pp. 13-21.
Cooper, J.D., et al., Accurate Counting of Neurons in Frozen Sections: Some Necessary Precautions, J. Anatomy, vol. 157, 1988, pp. 13 21. *
Doudkine, A, et al., "Nuclear Texture Measurements in Image Cytometry," Pathologica, vol. 87, 1995, pp. 286-299.
Doudkine, A, et al., Nuclear Texture Measurements in Image Cytometry, Pathologica, vol. 87, 1995, pp. 286 299. *
Dutt, M.K., "Use of Tris-Buffer-Fortified Thionine-SO2 for Detection of DNA-Aldehyde Following Feulgen Procedure," Microscopica Acta, vol. 83, No. 4, Sep. 1980, pp. 311-316.
Dutt, M.K., Use of Tris Buffer Fortified Thionine SO 2 for Detection of DNA Aldehyde Following Feulgen Procedure, Microscopica Acta , vol. 83, No. 4, Sep. 1980, pp. 311 316. *
Dutta et al., "Efect of organic solvents on dye-DNA interaction", Indian Journal of Chemistry, Nov. 1986. vol. 25A, pp. 1001-1003.
Dutta et al., Efect of organic solvents on dye DNA interaction , Indian Journal of Chemistry, Nov. 1986. vol. 25A, pp. 1001 1003. *
Feulgen, R., et al., Z. Physiol. Chem. vol. 136, 1924, pp. 57 61. *
Feulgen, R., et al., Z. Physiol. Chem. vol. 136, 1924, pp. 57-61.
Garner, D.M., et al., CytoSavant and Its Use in Automated Screening of Cervical Smears, in Compendium on The Computerized Cytology and Histology Laboratory, Wied, G.L., et al., eds., Tutorials of Cytology, Chicago, 1994. *
Humason, Gretchen L., Animal Tissue Techniques, 4th Ed., W.H. Freeman & Company, San Francisco, 1979, pp. 154 155, 181 183, 208, 316 319, 432 433, 471 473. *
Humason, Gretchen L., Animal Tissue Techniques, 4th Ed., W.H. Freeman & Company, San Francisco, 1979, pp. 154-155, 181-183, 208, 316-319, 432-433, 471-473.
Insausti, R., et al., "The Human Entorhinal Cortex: A Cytoarchitectonic Analysis," The Journal of Comparative Neurology, vol. 355, 1995, pp. 171-198.
Insausti, R., et al., The Human Entorhinal Cortex: A Cytoarchitectonic Analysis, The Journal of Comparative Neurology, vol. 355, 1995, pp. 171 198. *
Jaggi, B., et al., "Design of a Solid-State Microscope, "Optical Engineering, Jun. 1989, vol. 28 No. 6, pp. 675-682.
Jaggi, B., et al., "The Design and Development of an Optical Scanner for Cell Biology," IEEE Proceedings Engineering in Medicine and Biology Society, vol. 2, sep. 1985; pp. 980-985.
Jaggi, B., et al., Design of a Solid State Microscope, Optical Engineering, Jun. 1989, vol. 28 No. 6, pp. 675 682. *
Jaggi, B., et al., The Design and Development of an Optical Scanner for Cell Biology, IEEE Proceedings Engineering in Medicine and Biology Society, vol. 2, sep. 1985; pp. 980 985. *
Kutscher, Charles L., et al., "Hematoxylin and Thionin Techniques for Staining Myeline and Cells: Variations and Critical Steps," Brain Research Bulletin, vol. 19, 1987, pp. 161-163.
Kutscher, Charles L., et al., Hematoxylin and Thionin Techniques for Staining Myeline and Cells: Variations and Critical Steps, Brain Research Bulletin, vol. 19, 1987, pp. 161 163. *
Mikel, Ulrika V., et al., "A Comparative Study of Quantitative Stains for DNA in Image Cytometry," Analytical and Quantitative Cytology and Histology, vol. 13, No. 4, Aug. 1991, pp. 253-260.
Mikel, Ulrika V., et al., A Comparative Study of Quantitative Stains for DNA in Image Cytometry, Analytical and Quantitative Cytology and Histology, vol. 13, No. 4, Aug. 1991, pp. 253 260. *
Muto, Tetsuichiro, et al., "Mucin Abnormality in Colonic Mucosa in Patients with Familial Polyposis Coli," Seminars in Surgical Oncology, vol. 3, 1987, pp. 179-182.
Muto, Tetsuichiro, et al., Mucin Abnormality in Colonic Mucosa in Patients with Familial Polyposis Coli, Seminars in Surgical Oncology, vol. 3, 1987, pp. 179 182. *
Ota, H., et al., "A Dual Staining Method for Identifying Mucins of Different Gastric Epithelial Mucous Cells," Histochemical Journal, vol. 23, 1991, pp. 22-28.
Ota, H., et al., A Dual Staining Method for Identifying Mucins of Different Gastric Epithelial Mucous Cells, Histochemical Journal, vol. 23, 1991, pp. 22 28. *
Poon, S.S.S., et al., "Cell Recognition Algorithms for the Cell Analyzer," IEEE Proceedings Engineering in Medicine and Biology Society, vol. 4, Nov. 1987; pp. 1454-1456.
Poon, S.S.S., et al., Cell Recognition Algorithms for the Cell Analyzer, IEEE Proceedings Engineering in Medicine and Biology Society, vol. 4, Nov. 1987; pp. 1454 1456. *
Schulte, E., et al., "The Influence of Cationic Thiazine Dyes on Eosin Y-Uptake of Red Blood Cells in Romanowsky-Giemsa Type," Acta Histochemica, Suppl.-Band XXXVII, S., 1989, pp. 139-147.
Schulte, E., et al., The Influence of Cationic Thiazine Dyes on Eosin Y Uptake of Red Blood Cells in Romanowsky Giemsa Type, Acta Histochemica, Suppl. Band XXXVII, S., 1989, pp. 139 147. *
Schulte, Erik, M.D., "Air Drying as a Preparatory Factor in Cytology: Investigation of its Influence on Dye Uptake and Dye Binding," Diagnostic Cytopatholgy, vol. 2, No. 2, Apri.-Jun. 1986, pp. 160-167.
Schulte, Erik, M.D., Air Drying as a Preparatory Factor in Cytology: Investigation of its Influence on Dye Uptake and Dye Binding, Diagnostic Cytopatholgy, vol. 2, No. 2, Apri. Jun. 1986, pp. 160 167. *
Schulte, Erik, M.D., et al., "Standardization of the Papanicolaou Stain: I. A Comparison of Five Nuclear Stains," Analytical and Quantitative Cytology and Histology, vol. No. 3, Jun. 1990, pp. 149-156.
Schulte, Erik, M.D., et al., Standardization of the Papanicolaou Stain: I. A Comparison of Five Nuclear Stains, Analytical and Quantitative Cytology and Histology, vol. No. 3, Jun. 1990, pp. 149 156. *
St o rmer, V.U., et al., Staining Properties and Applicability of Spectrally Pure Thionine and its Isomeres, Acta histochem., vol. 70, 1982, pp. 161 172. *
Stormer, V.U., et al., "Staining Properties and Applicability of Spectrally Pure Thionine and its Isomeres," Acta histochem., vol. 70, 1982, pp. 161-172.
Tolivia, J., et al., "Differential Technique to Stain Nerve Cells and Fibers in Methacrylate Sections," The Anatomical Record, vol. 217, 1987, pp. 318-320.
Tolivia, J., et al., "Differential Thionin Block Staining of Nerve Cells and Fibers for Paraffin-Embedded Material in Mammalian Central Nervous System,"Neuroscience Letters, vol. 102, 1989, pp. 155-158.
Tolivia, J., et al., Differential Technique to Stain Nerve Cells and Fibers in Methacrylate Sections, The Anatomical Record, vol. 217, 1987, pp. 318 320. *
Tolivia, J., et al., Differential Thionin Block Staining of Nerve Cells and Fibers for Paraffin Embedded Material in Mammalian Central Nervous System, Neuroscience Letters, vol. 102, 1989, pp. 155 158. *
Van Duijn, P., "A Histochemical Specific Thionine-SO2 Reagent and its Use in a Bi-Color Method for Deoxyribonucleic Acid and Periodic Acid Schiff Positive Substances," J. Histochem. Cytochem., vol 4, 1956, pp. 55-63.
Van Duijn, P., A Histochemical Specific Thionine SO 2 Reagent and its Use in a Bi Color Method for Deoxyribonucleic Acid and Periodic Acid Schiff Positive Substances, J. Histochem. Cytochem., vol 4, 1956, pp. 55 63. *
Winzek, C., et al., "An Improved Method to Investigate Staining Kinetics in Single Cells," Histochemistry, vol. 86, 1987, pp. 421-426.
Winzek, C., et al., "Staining Kinetics in Single Cells: Part II. Diffusion Processes Inside the Cell," Histochemistry, vol. 90, 1988, pp. 79-83.
Winzek, C., et al., An Improved Method to Investigate Staining Kinetics in Single Cells, Histochemistry, vol. 86, 1987, pp. 421 426. *
Winzek, C., et al., Staining Kinetics in Single Cells: Part II. Diffusion Processes Inside the Cell, Histochemistry, vol. 90, 1988, pp. 79 83. *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060161099A1 (en) * 1998-07-15 2006-07-20 Constantz Brent R Methods and devices for reducing the mineral content of vascular calcified lesions
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US8500683B2 (en) 1999-08-27 2013-08-06 Cordis Corporation Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US20050059955A1 (en) * 1999-10-22 2005-03-17 Dave Delaney Catheter devices and methods for their use in the treatment of calcified vascular occlusions
US20070173784A1 (en) * 1999-10-22 2007-07-26 Peter Johansson Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
US6348325B1 (en) 1999-10-29 2002-02-19 Cytyc Corporation Cytological stain composition
US6593102B2 (en) 1999-10-29 2003-07-15 Cytyc Corporation Cytological stain composition
US20040042646A1 (en) * 2002-08-29 2004-03-04 Macaulay Calum E. Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer
US7274809B2 (en) 2002-08-29 2007-09-25 Perceptronix Medical, Inc. And British Columbia Cancer Agency Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer
US7153691B2 (en) 2002-11-13 2006-12-26 G6 Science Corp. Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20040092026A1 (en) * 2002-11-13 2004-05-13 Ferguson Gary William Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents
US20050202524A1 (en) * 2004-03-15 2005-09-15 Brusilovskiy Arkadiy I. Tissue staining protocol and composition
US20060199243A1 (en) * 2005-03-03 2006-09-07 Garner David M Cytological stain composition and methods of use
CN111879592A (en) * 2020-08-25 2020-11-03 湖南品胜生物技术有限公司 Anti-falling cell DNA quantitative staining solution and preparation method thereof
CN111999144A (en) * 2020-08-25 2020-11-27 湖南品胜生物技术有限公司 Anti-falling cell DNA quantitative staining method

Also Published As

Publication number Publication date
JP2001509591A (en) 2001-07-24
AU8202998A (en) 1999-02-08
EP0996852A1 (en) 2000-05-03
JP4212232B2 (en) 2009-01-21
CA2295545C (en) 2010-02-02
WO1999002960A8 (en) 1999-08-05
WO1999002960A1 (en) 1999-01-21
CA2295545A1 (en) 1999-01-21

Similar Documents

Publication Publication Date Title
US5942410A (en) Composition and method for staining cellular DNA, comprising thiazine derivative metabisulfite and methanol or ethanol
Chieco et al. The Feulgen reaction 75 years on
US5109429A (en) Apparatus and method for analyses of biological specimens
US5485527A (en) Apparatus and method for analyses of biological specimens
AU766614B2 (en) Removal of embedding media from biological samples and cell conditioning on automated staining instruments
US4857300A (en) Cytological and histological fixative formulation and methods for using same
US20060041385A1 (en) Method of quantitating proteins and genes in cells using a combination of immunohistochemistry and in situ hybridization
EP2392909B1 (en) Methods for a microemulsion-based tissue treatment
US20030175852A1 (en) Ehancement of in situ hybridization
Biel et al. From tissue to cellular ultrastructure: closing the gap between micro‐and nanostructural imaging
US5804448A (en) Method of staining cellular material and analyzing the same
JP2005509140A (en) A robust method for detecting and quantifying stains in histological specimens based on a physical model of stain absorption
EP0248840A1 (en) An apparatus and method for analyses of biological specimens.
JP2012034699A (en) Universal collection medium
Stöhr et al. The Heidelberg flow analyzer and sorter (HEIFAS) approach on the prescreening of uterine cancer.
US20060199243A1 (en) Cytological stain composition and methods of use
Franklin et al. A new technique for retarding fading of fluorescence: DPX-BME
Woodruff et al. Advantages of glycol methacrylate embedding systems for light microscopy
Van der Ploeg et al. Dual wavelength scanning cytophotometry (BICOSCAN)
CA2341421C (en) Removal of embedding media from biological samples and cell conditioning on automated staining instruments
Bottiroli et al. Propidium iodide and the thiol‐specific reagent dacm as a dye pair for fluorescence resonance energy transfer analysis: An application to mouse sperm chromatin
JP3553691B2 (en) Reticulocyte measuring reagent and measuring method
Dykstra et al. Staining methods for semithins and ultrathins
Willingham et al. Morphologic methods in the study of endocytosis in cultured cells
Wadsworth et al. Quantitative analysis of atherosclerotic lesion composition in mice

Legal Events

Date Code Title Description
AS Assignment

Owner name: ONCOMETRICS IMAGING CORP., CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAM, PAUL PONG-SHING;PAYNE, PETER WILLIAM;GARNER, DAVID MICHAEL;AND OTHERS;REEL/FRAME:009492/0090

Effective date: 19970917

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
AS Assignment

Owner name: MONOGEN, INC., ILLINOIS

Free format text: LICENSE AND SECURITY AGREEMENT;ASSIGNOR:ONCOMETRICS IMAGING CORP.;REEL/FRAME:013718/0264

Effective date: 20021223

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 4

SULP Surcharge for late payment
AS Assignment

Owner name: MUSIKANTOW-GOMBRICH, SUZANNE, ILLINOIS

Free format text: SECURITY INTEREST;ASSIGNOR:MOLECULAR DIAGNOSTICS, INC.;REEL/FRAME:014517/0567

Effective date: 20030925

FEPP Fee payment procedure

Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

AS Assignment

Owner name: MOLECULAR DIAGNOSTICS, INC., ILLINOIS

Free format text: SECURITY INTEREST TERMINATION;ASSIGNOR:MUSIKANTOW-GOMBRICH, MS. SUZANNE;REEL/FRAME:015201/0247

Effective date: 20040412

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: BRITISH COLUMBIA CANCER AGENCY BRANCH, CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CYTOCORE INC.;ACCUMED INTERNATIONAL, INC.;ONCOMETRICS IMAGING CORP.;REEL/FRAME:019704/0764

Effective date: 20070802

AS Assignment

Owner name: PERCEPTRONIX MEDICAL INC., CANADA

Free format text: EXCLUSIVE LICENSE;ASSIGNOR:THE BRITISH COLUMBIA CANCER AGENCY BRANCH;REEL/FRAME:019899/0775

Effective date: 20070824

FPAY Fee payment

Year of fee payment: 12